National Prostate Cancer Audit

Background

Background

Prostate cancer is the most common solid cancer in men with 40,000 new cases diagnosed each year in the UK and its incidence is increasing. There are concerns about over-diagnosis and over-treatment in men with low-risk disease, while men with locally advanced or high-risk disease may not be getting the radical treatments that they need. The first NPCA was commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit Programme in response to the need for better information about the quality of services and care provided to patients with prostate cancer in England and Wales.

The audit will be undertaken at the Clinical Effectiveness Unit (CEU) of the Royal College of Surgeons which has an excellent track record of producing high quality national cancer audits including the recently updated national gastro-oesophageal cancer audit. Uro-oncology leadership is provided by Professor Noel Clarke, Consultant Urologist, representing the British Association of Urological Surgeons and Dr Heather Payne, Consultant Clinical Oncologist, representing the British Uro-Oncology Group.

Cancer data collection expertise is provided by Dr Jem Rashbass, National Director for Disease Registration, Public Health England. The methodology and program sequence has been put in place by Professor Jan van de Meulen, who has been involved in the synthesis of large scale national cancer audits and is based at the CEU and at The London School of Hygiene and Tropical medicine.